Loading
AgTech Navigator News
-
S2G Investments has closed a $1 billion Solutions Fund I to support growth-stage companies addressing critical challenges in food, agriculture, energy, and ocean systems, with a focus on the underserved “missing middle” between early-stage venture capital and large-scale infrastructure funding. The fund targets proven technologies ready to scale, reflecting rising investor interest in supply chain resilience amid geopolitical instability, and will primarily invest in North America and Europe in sectors where food, energy, and ocean systems intersect. S2G has already deployed $300 million across 10 companies, including an early exit with Urbint, and aims to drive efficiency and resilience across core economic systems. The firm’s approach emphasizes scaling commercially viable innovations to address global economic and environmental challenges.
-
Resurrect Bio, a UK ag-biotech spinout, has closed an oversubscribed $10.3 million Series A funding round led by Corteva, bringing its total funding to $12.4 million. The company uses AI-driven gene editing to unlock dormant disease-resistance traits in crops, aiming to reduce reliance on chemical pesticides and speed up the integration of durable resistance into commercial breeding pipelines. Strategic backing from major industry players and joint development agreements signal strong industry confidence in gene-edited crop immunity as an alternative to traditional chemical solutions. With new capital, Resurrect Bio is shifting from proof-of-concept to commercial integration, positioning itself at the forefront of sustainable crop protection.
-
BASF has opened a new high-investment fermentation facility, the BioHub, at its Ludwigshafen site in Germany to scale up production of biological crop protection products and intermediates. This move reduces reliance on external manufacturers, enhances supply chain resilience, and offers manufacturing flexibility to adapt to changing market demands. By integrating R&D with industrial-scale production, BASF aims to accelerate innovation and bring new biological actives to market more quickly, supporting its strategy to balance conventional and sustainable solutions amid regulatory and industry pressures. The facility is also expected to improve process efficiency and sustainability through infrastructure synergies and lower energy intensity.